Comparative review of the effects of inhaled beclomethasone dipropionate and budesonide on bone

Respiratory Medicine

Volumn 92, Issue SUPPL. B, 1998, Pages 24-36

  D'Souza, M ^a  

^a Roy Brompton Natl Heart Lung Inst   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; OSTEOCALCIN;

ASTHMA; BONE; BONE ATROPHY; BONE DENSITY; BONE METABOLISM; BONE TURNOVER; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE PREDISPOSITION; DISEASE SEVERITY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; OSTEOPOROSIS; POSTMENOPAUSE; PRIORITY JOURNAL; REVIEW;

EID: 0031659425     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(98)90437-1     Document Type: Review

References (49)

1. Adinoff AD, Hollister JR. Steroid-induced fractures and bone loss in patients with asthma. New Engl J Med 1983; 309: 265-268.
2. Hanania NA, Chapman KR, Kesten S. Adverse effects of inhaled corticosteroids. Am J Med 1995; 98: 196-208.
3. Luckert BP, Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 352-364.
4. Truhan AP, Ahmed AR. Corticosteroids: a review with emphasis on complications of prolonged systemic therapy. Ann Allergy 1989; 62: 375-391.
5. Williams SJ. Side effects of inhaled steroids. In: Hargreave FE, Hogg JC, Malo JL, Toogood JH, eds. Glucocorticoids and Mechanism of Asthma. Clinical and Experimental Aspects (Toronto, 18-19 November 1988). Amsterdam: Excerpta Medica. and AB Draco, 1989.
6. British Asthma Guidelines Coordination Committee. British guidelines on asthma management: 1995 review and position statement. Thorax 1997; 52: S1-S24.
7. Hodsman AB, Toogood JH, Jennings B et al. Differential effects of inhaled budesonide and oral prednisolone on serum osteocalcin. J Clin Endocrinol Metab 1991; 72: 530-540.
8. Jennings BH, Andersson K-E, Johansson SA. Assessment of the systemic effects of inhaled glucocorticosteroids: comparison of the effects of inhaled budesonide and oral prednisolone on adrenal function and markers of bone turnover. Eur J Clin Pharmacol 1991; 40: 77-82.
9. Jennings BH, Andersson K-E, Johansson S-A. The assessment of the systemic effects of inhaled glucocorticosteroids. Eur J Clin Pharmacol 1991; 41: 11-16.
10. Meeran K, Hattersley A, Burrin J et al. Oral and inhaled corticosteroids suppress bone formation. Am Rev Respir Dis 1991; 143: 625.
11. 4) metabolism. Ann Allergy 1985; 55: 257.
12. Peretz A, Bourboux PP. Inhaled steroids, bone formation and osteocalcin. Lancet 1991; 338: 1340.
13. Pouw EM, Prummel MF, Oosting H et al. Beclomethasone inhalation decreases serum osteocalcin concentrations. Br Med J 1991; 302: 627-628.
14. Teelucksingh S, Padfield PL, Tibi L et al. Inhaled steroids, bone formation and osteocalcin. Lancet 1991; 338: 60-61.
15. Toogood JH, Jennings B, Hodsman AB et al. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991; 88: 572-580.
16. Ali NJ, Capewell S, Ward MJ. Bone turnover during high dose inhaled corticosteroid treatment. Thorax 1991; 46: 160-164.
17. Brown PH, Matusiewicz Santa Ponça, Shearing C et al. Systemic effects of high dose inhaled steroids: comparison of beclomethasone dipropionate and budesonide in healthy subjects. Thorax 1993; 48: 967-973.
18. Jennings BH, Larsson B, Andersson K-E et al. A comparison of budesonide and beclomethasone in healthy volunteers. The assessment of systemic effects of inhaled glucocorticoids. Univ Lund 1990; VII: 1-14.
19. Leech JA, Hodder RV, Ooi DS et al. Effects of short-term inhaled budesonide and beclomethasone dipropionate on serum osteocalcin in premenopausal women. Am Rev Respir Dis 1993; 148: 113-115.
20. Reid DM. Corticosteroid-induced osteoporosis. In: Smith R, ed. Osteoporosis. London: Royal College of Physicians of London, 1990; pp. 99-117.
21. Boulet L-P, Giguère M-C, Milot J, Brown J. Effects of long-term use of high-dose inhaled steroids on bone density and calcium metabolism. J Allergy Clin Immunol 1994; 94: 796-803.
22. Hanania NA, Chapman KR, Sturtridge WC, Szalai JP, Kesten S. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J Allergy Clin Immunol 1995; 96: 571-579.
23. Kerstjens HAM, Postma DS, van Doormael JJ et al. Effects of short term and long term treatment with inhaled corticosteroids on bone metabolism in patients with airways obstruction. Thorax 1994; 49: 652-656.
24. Luengo M, Picada C, Piera C et al. Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. Eur Respir J 1991; 4: 441-444.
25. Luengo M, Del Rio L, Guanabens N et al. Long-term effect of oral and inhaled glucocorticoids on bone mass in chronic asthma. A two year follow up study. Eur Respir J 1991; 4(Suppl. 14): 342s.
26. Packe GE, Douglas JG, McDonald AF et al. Bone density in asthmatic patients taking high dose inhaled beclomethasone dipropionate and intermittent systemic corticosteroids. Thorax 1992; 47: 414-417.
27. Packe GE, Robb O, Robins Santa Ponça, Reid DM, Douglas JG. Bone density in asthmatic patients taking inhaled corticosteroids: comparison of budesonide and beclomethasone dipropionate. Thorax 1993; 48: 1056-1060.
28. Wolff AH, Adelsberg B, Aloia J et al. Effect of inhaled corticosteroids on bone density in asthmatic patients: a pilot study. Ann Allergy 1991; 67: 117-121.
29. Morrison D, Richards R, Ali N et al. Comparison of budesonide and beclomethasone dipropionate on indices of bone turnover in COAD. Thorax 1994; 49: 403P-404P.
30. Rubin CD. Southwestern Internal Medicine Conference: age-related osteoporosis. Am J Med Sci 1991; 301: 281-298.
31. Allen SH. Primary osteoporosis: methods to combat bone loss that accompanies aging. Postgrad Med 1993; 93: 43-55.
32. Puolijoki H, Liipo K, Herrala J et al. Does high dose inhaled beclomethasone (BDP) affect the calcium metabolism? Eur Respir J 1991; 1: abstract 1061.
33. Stead RJ, Horsman A, Cooke NJ et al. Bone mineral density in women taking inhaled corticosteroids. Thorax 1990; 45: 792.
34. Baraldi E, Bollini MC, De Marchi A et al. Effect of beclomethasone dipropionate on bone mineral content assessed by X-ray densitometry in asthmatic children: a longitudinal evaluation. Eur Respir J 1994; 7: 710-714.
35. Birkbaek NH, Esberg G, Andersen K, Wolthers O, Hassanger C. Bone and collagen turnover during treatment with inhaled dry powder budesonide and beclomethasone dipropionate. Arch Dis Child 1995; 73: 524-527.
36. Doull IJM, White M, Freezer NJ et al. Markers of bone metabolism in asthmatic children receiving inhaled corticosteroids. Eur Respir J 1994; 7(Suppl. 18): 28s.
37. Konig P, Hillman L, Cervantes C et al. Bone metabolism in children with asthma treated with inhaled beclomethasone dipropionate. J Paediatr 1993; 122: 219-226.
38. Priftis K, Vosaki I, Papadimitrou A et al. Effects of long-term treatment with inhaled steroids on bone metabolism in asthmatic children. Eur Respir J 1994; 7(Suppl. 18): 28s.
39. Huskisson SC, Meades CR, Cuss FM, Palmer JBD. Inhaled beclomethasone dipropionate. Greenford: Castle Press Abetwyth, Glaxo Group Research Ltd, 1987.
40. Power MJ, Fottrell PF. Osteocalcin: diagnostic methods and clinical applications. Crit Rev Clin Lab Sci 1991; 28: 287-335.
41. Glowacki J, Lian JB. Impaired recruitment and differentiation of osteoclast progenitors by osteocalcin-deplete bone implants. Cell Differ 1987; 21: 247-254.
42. Reid DM. Methods of measurement of bone turnover and clinical evaluation of osteoporosis: relevance to asthma and corticosteroid therapy. Respir Med 1993; 87(Suppl. A): 9-14.
43. Newman SP, Pavia D, Moren F, Sheahan NF, Clarke SW. Deposition of pressurized aerosols in the human respiratory tract. Thorax 1981; 36: 52-55.
44. Newman SP, Millar AB, Lennard-Jones TR, Moren F, Clarke SW. Improvement of pressurised aerosol deposition with Nebuhaler spacer device. Thorax 1984; 39: 935-941.
45. Selroos O, Backman R, Forsén K-O et al. Local side-effects during 4-year treatment with inhaled corticosteroids - a comparison between pressurized metered-dose inhalers and Turbuhaler®. Allergy 1994; 49: 888-890.
46. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson S-A. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984; 129: 723-729.
47. Toogood JH, Jennings B, Baskerville J, Anderson J, Johansson SA. Dosing regimen of budesonide and occurrence of oropharyngeal complications. Eur J Respir Dis 1984; 65: 35-44.
48. Newman SP, Moren F, Trofast E, Talalee N, Clarke SW. Deposition and clinical efficacy of terbutaline sulphate from Turbuhaler, a new multi-dose powder inhaler. Eur Respir J 1989; 2: 247-252.
49. Petrie GR, Choo-Kong YFJ, Clark RA et al. An assessment of the acceptability of two breath-actuated corticosteroid inhalers: comparison of Turbuhaler and Diskhaler. Drug Invest 1990; 2: 129-131.